Locally advanced or metastatic breast cancer Clinical Trials
Conditions / Locally advanced or metastatic breast cancer
Delta Trials tracks 16 clinical trials for Locally advanced or metastatic breast cancer in its publicly accessible dataset. Among the listed trials, 5 open for participant enrollment and 4 trials have reached completion. This research is carried out at 338 clinical sites around the world. An additional 7 trials have active registrations outside the recruiting and completed categories. Since 2020, 1 trial have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the research landscape.
Trial Status
16
Total Trials
5
Recruiting
4
Completed
7
Other Active
1
Terminated since 2020
338
Study Locations
Browse by location (338 total)
- Guangzhou, China 7 trialsAll trials in Guangzhou, China
- Beijing, China 6 trialsAll trials in Beijing, China
- Fuzhou, China 5 trialsAll trials in Fuzhou, China
- Changchun, China 5 trialsAll trials in Changchun, China
- Bengbu, China 4 trialsAll trials in Bengbu, China
- Shanghai, China 4 trialsAll trials in Shanghai, China
- Shenyang, China 4 trialsAll trials in Shenyang, China
- Hangzhou, China 4 trialsAll trials in Hangzhou, China
- Nanjing, China 4 trialsAll trials in Nanjing, China
- Wuhan, China 4 trialsAll trials in Wuhan, China
- Tianjin, China 4 trialsAll trials in Tianjin, China
- Yinchuan, China 3 trialsAll trials in Yinchuan, China
- Chengdu, China 3 trialsAll trials in Chengdu, China
- Luoyang, China 3 trialsAll trials in Luoyang, China
- Jinan, China 3 trialsAll trials in Jinan, China
- Jinan, China 3 trialsAll trials in Jinan, China
- Shijiazhuang, China 3 trialsAll trials in Shijiazhuang, China
- Anyang, China 3 trialsAll trials in Anyang, China
- Kunming, China 3 trialsAll trials in Kunming, China
- Nanchang, China 3 trialsAll trials in Nanchang, China